Vaccitech
  • Home
  • About
    • Our Team
  • Technology
    • Science
  • Pipeline
  • Partnerships
  • News & Updates
    • Newsroom
    • Events
  • Careers
  • Contact
Select Page

News & Updates Learn more HELLO WORLD ILLUSTRATOR WRITER WEB-DESIGNER

VANCE: First in Human Phase I Study of a Novel ChAdOx1-MVA 5T4 Vaccine

Jun 5, 2018

View/Download ASCO 2018 Poster

Recent Posts

  • Vaccitech and Oxford University Announce Promising Phase 2a Data on Prostate Cancer Immunotherapy
  • Vacancy: Clinical Programme Lead
  • Phase 2 Clinical Results for Vaccitech’s Universal Influenza A Vaccine
  • New MERS Coronavirus vaccine clinical trial starts in Saudi Arabia
  • Vaccitech Oncology Limited enters collaboration with Cancer Research UK to fund a Phase I/IIa clinical trial as first-line NSCLC therapy

Vaccitech Limited

The Schrödinger Building
Heatley Road
The Oxford Science Park
Oxford
OX4 4GE

T: +44 (0)1865 818808

  • Home
  • About
  • Sitemap
  • Privacy Policy
  • Privacy Notice
  • Careers
  • Contact

Vaccitech is a T cell immunotherapy company developing products to treat and prevent infectious disease and cancer

  • Twitter
  • LinkedIn
© Vaccitech 2019 All rights reserved. Website by Brand Cooke